Virtu Financial LLC Arca Biopharma, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$2.13 - $25.68 $30,290 - $365,195	14,221 New	14,221 $29,000
Q2 2022 Aug 09, 2022	SELL	$2.2 - $2.53 $52,522 - $60,401	-23,874 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.77 - $2.49 $42,256 - $59,446	23,874 New	23,874 $55,000
Q2 2021 Sep 17, 2021	SELL	$3.06 - $3.9 $50,964 - $64,954	-16,655 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$3.48 - $5.3 $27,791 - $42,325	-7,986 Reduced 32.41%	16,655 $61,000
Q4 2020 Feb 24, 2021	BUY	$3.74 - $5.18 $92,157 - $127,640	24,641 New	24,641 $99,000

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.